title: Fusobacterium invasive infections in children: a retrospective study in two French tertiary care centres.
abstract: The purpose of this investigation was to describe the clinical and biological characteristics and evolution of invasive Fusobacterium infections in children admitted to two French paediatric tertiary care centres. Children who were admitted from 1998 to 2009 to two tertiary care centres for invasive Fusobacterium infection were included in a retrospective study. Thirty-one children with a median age of 5.7 years (interquartile range, IQR [2.3; 9.3]) were included. Nine children had an underlying condition, most commonly sickle cell disease (n = 3) or immunodeficiency (n = 3). Two children had skin effraction prior to the infection. The major sites of infection were the head and neck (n = 14) and abdomen (n = 10). Three children suffered from atypical Lemierre's syndrome. More than half of the children had a bacterial co-infection (58 %). Six children were hospitalised in an intensive care unit, and 67 % of them had a chronic underlying disease. None of the children died. Six children with negative cultures had Fusobacterium identified through 16S RNA-PCR. Fusobacterium is responsible for severe infection in children. Microbiological diagnosis might be improved by the wider use of molecular detection.
authors.affiliation: Hôpital Pellegrin, Pédiatrie Médicale, CHU de Bordeaux, Place Amélie Raba-Léon, 33000 Bordeaux, France. marion.bailhache@free.fr
authors.forename: M
authors.initials: M
authors.lastname: Bailhache
authors.forename: P
authors.initials: P
authors.lastname: Mariani-Kurkdjian
authors.forename: P
authors.initials: P
authors.lastname: Lehours
authors.forename: J
authors.initials: J
authors.lastname: Sarlangue
authors.forename: P
authors.initials: P
authors.lastname: Pillet
authors.forename: E
authors.initials: E
authors.lastname: Bingen
authors.forename: A
authors.initials: A
authors.lastname: Faye
mesh_terms: D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016009:Chi-Square Distribution; D002648:Child; D002675:Child, Preschool; D005260:Female; D005602:France / Q000453:epidemiology; D005673:Fusobacterium / Q000302:isolation & purification*; D005674:Fusobacterium Infections / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology; D006801:Humans; D007223:Infant; D008297:Male; D012189:Retrospective Studies; D012307:Risk Factors; D018709:Statistics, Nonparametric; D062606:Tertiary Care Centers
chemical_list: D000900:Anti-Bacterial Agents